FDA Inspection 1271715 — TTY BioPharm Company Ltd (Chungli Factory)
The FDA completed an inspection of TTY BioPharm Company Ltd (Chungli Factory) on May 2, 2025 in Taoyuan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 2, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taoyuan (Taiwan)